2025-06-30 – Press Releases – www.prnewswire.com
TOKYO, June 30, 2025 /PRNewswire/ — AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapies for hematologic cancers and autoimmune diseases, today announced it has been awarded a grant of…
